Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
Open Access
- 15 March 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 136 (6) , 2287-2292
- https://doi.org/10.4049/jimmunol.136.6.2287
Abstract
The protective immunogenicity of chemically synthesized copies of the NH2-terminal region of type 6 streptococcal M protein was investigated. Four overlapping peptides were synthesized by copying residues 1-20, 10-20, 12-31, and 22-31. Rabbit antisera raised against whole cells of type 6 streptococci reacted at high dilutions (1/12,800 to 1/51,200) with S-M6(1-20) and S-M6(10-20), and at low dilutions (1/100-1/800) with S-M6(12-31) and S-M6(22-31), indicating that the NH2-terminal region of type 6 M protein bears immunodominant epitopes. When covalently linked to tetanus toxoid and emulsified in complete Freund's adjuvant, the synthetic peptides S-M6(1-20), S-M6(10-20), and S-M6(12-31), but not S-M6(22-31), evoked type-specific opsonic antibodies against type 6 streptococci. Although the immune sera reacted in low dilutions by enzyme linked immunoabsorbent assay (ELISA) with the heterologous M protein polypeptides pep M5, pep M19, and pep M24, they failed to opsonize the streptococci from which these M protein polypeptides were derived. Each of the immune sera reacted in high dilution by ELISA with the respective immunizing peptides. All except those against S-M6(22-31) also reacted with pep M6. None of the immune sera reacted with human cardiac tissue by immunofluorescence or with muscle myosin by ELISA. The pattern of the inhibition of opsonization by each of the synthetic peptides of each of the immune sera indicates the presence of at least three protective epitopes in the NH2-terminal region of type 6 M protein. Our results indicate that the NH2-terminal region of type 6 M protein contains both protective and nonprotective epitopes, and chemically synthesized copies of this region lack cardiac tissue cross-reactive epitopes. These studies hold promise for the development of safe and effective vaccines against group A streptococci, especially against the strains giving rise to rheumatic fever and rheumatic heart disease.This publication has 17 references indexed in Scilit:
- Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart.The Journal of Experimental Medicine, 1982
- Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.Proceedings of the National Academy of Sciences, 1981
- Primary structure of protective antigens of type 24 streptococcal M protein.Journal of Biological Chemistry, 1980
- Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule.The Journal of Experimental Medicine, 1980
- Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.The Journal of Immunology, 1980
- Primary structural similarities between types 5 and 24 M proteins of StreptococcuspyogenesBiochemical and Biophysical Research Communications, 1980
- Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.The Journal of Experimental Medicine, 1979
- Repeating covalent structure of streptococcal M protein.Proceedings of the National Academy of Sciences, 1978
- Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigenThe Journal of Experimental Medicine, 1977
- Current Knowledge of Type-Specific M Antigens of Group A StreptococciThe Journal of Immunology, 1962